N-(3-((5-Methoxyquinolin-2-yl)amino)phenyl)-4-morpholino-3-(trifluoromethyl)benzamide

ID: ALA4743339

PubChem CID: 156597426

Max Phase: Preclinical

Molecular Formula: C28H25F3N4O3

Molecular Weight: 522.53

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cccc2nc(Nc3cccc(NC(=O)c4ccc(N5CCOCC5)c(C(F)(F)F)c4)c3)ccc12

Standard InChI:  InChI=1S/C28H25F3N4O3/c1-37-25-7-3-6-23-21(25)9-11-26(34-23)32-19-4-2-5-20(17-19)33-27(36)18-8-10-24(22(16-18)28(29,30)31)35-12-14-38-15-13-35/h2-11,16-17H,12-15H2,1H3,(H,32,34)(H,33,36)

Standard InChI Key:  UJDNEVXCAKHSDH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
   26.5068  -18.0499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5057  -18.8773    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2205  -19.2901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2187  -17.6372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9340  -18.0463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9348  -18.8731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6501  -19.2841    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.3652  -18.8693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3604  -18.0393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6445  -17.6321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2157  -16.8123    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.9288  -16.3974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0788  -19.2830    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.7940  -18.8717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5053  -19.2899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2200  -18.8793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2218  -18.0535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5030  -17.6399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7913  -18.0529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9321  -19.2946    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.6483  -18.8851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3610  -19.3007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6518  -18.0602    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.3561  -20.1260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0679  -20.5415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7852  -20.1320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7860  -19.3027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0736  -18.8910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4976  -18.8886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1968  -19.3595    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   36.4991  -20.5493    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.4890  -21.3732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1987  -21.7905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9195  -21.3844    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.9260  -20.5566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2117  -20.1347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0851  -18.1742    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   36.9101  -18.1742    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  4 11  1  0
 11 12  1  0
  8 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 16 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 22 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 22  1  0
 29 30  1  0
 27 29  1  0
 26 31  1  0
 31 32  1  0
 31 36  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 29 37  1  0
 29 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4743339

    ---

Associated Targets(Human)

Panel NCI-60 (60 carcinoma cell lines) (1088 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAF1 Tclin Serine/threonine-protein kinase RAF (4169 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRAF Tclin Serine/threonine-protein kinase B-raf (11587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 522.53Molecular Weight (Monoisotopic): 522.1879AlogP: 6.09#Rotatable Bonds: 6
Polar Surface Area: 75.72Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 5.70CX LogP: 5.87CX LogD: 5.86
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.32Np Likeness Score: -1.57

References

1. El-Damasy AK,Haque MM,Park JW,Shin SC,Lee JS,EunKyeong Kim E,Keum G.  (2020)  2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAF/C-RAF kinase inhibitory effects: Design, synthesis, in vitro cell-based and oncogenic kinase assessments.,  208  [PMID:32942186] [10.1016/j.ejmech.2020.112756]

Source